Want to see MTLS full AI Analyst Report?
MTLS Stock Chart & Stats
$6.67
-$0.10(-1.53%)
At close: 4:00 PM EDT
$6.67
-$0.10(-1.53%)
Day’s Range― - ―
52-Week Range$4.78 - $7.50
Previous CloseN/A
Volume24.86K
Average Volume (3M)88.48K
Market Cap
$425.87M
Enterprise Value$348.44
Total Cash (Recent Filing)$133.68M
Total Debt (Recent Filing)$59.50M
Price to Earnings (P/E)26.5
Beta1.30
Next Earnings
Oct 28, 2026EPS Estimate
0.02Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.23
Shares Outstanding59,067,184
10 Day Avg. Volume145,779
30 Day Avg. Volume88,476
Financial Highlights & Ratios
PEG Ratio-0.84
Price to Book (P/B)1.09
Price to Sales (P/S)1.09
P/FCF Ratio30.53
Enterprise Value/Market Cap<0.01
Enterprise Value/Revenue<0.01
Enterprise Value/Gross Profit<0.01
Enterprise Value/Ebitda<0.01
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)0.18
Revenue Forecast (FY)$279.13M
Bulls Say, Bears Say
Bulls Say
Medical Segment Growth And MarginsStrong medical growth and a 31% EBITDA margin support durable earnings quality. Expanding patient-specific solutions, implants and hospital adoption can deepen customer relationships and provide a scalable foundation for future growth.
Net Cash And Improving Cash GenerationA net cash balance and stronger operating cash flow give Materialise financial flexibility to fund R&D, pursue strategic investments and withstand demand variability. This reduces reliance on external capital while supporting continued product development.
Recurring Software Platform ExpansionThe shift toward recurring software and broader CO-AM adoption can improve revenue visibility over time. HP distribution embeds Materialise workflow tools in new printer installations, expanding market reach and potential customer conversion.
Bears Say
Software Revenue Decline And Transition PressureSoftware is strategically important, yet current declines and longer sales cycles may delay growth. The transition from perpetual licenses to subscriptions can also pressure near-term revenue recognition and margins while investment in functionality remains high.
Manufacturing Profitability Remains WeakManufacturing has not yet demonstrated consistent operating leverage, leaving group profitability exposed to utilization and demand swings. Persistent weakness in prototyping and near-breakeven results could limit the segment's contribution to durable earnings.
Volatile Free Cash Flow ConversionAlthough cash generation recently improved, inconsistent free cash flow conversion indicates that working capital and investment requirements can materially affect cash outcomes. This may constrain the consistency of reinvestment and shareholder returns.
Materialise News
MTLS FAQ
What was Materialise NV’s price range in the past 12 months?
Materialise NV lowest stock price was $4.78 and its highest was $7.50 in the past 12 months.
What is Materialise NV’s market cap?
Materialise NV’s market cap is $425.87M.
When is Materialise NV’s upcoming earnings report date?
Materialise NV’s upcoming earnings report date is Oct 28, 2026 which is in 55 days.
How were Materialise NV’s earnings last quarter?
Materialise NV released its earnings results on Aug 27, 2026. The company reported $0.07 earnings per share for the quarter, beating the consensus estimate of $0.047 by $0.023.
Is Materialise NV overvalued?
According to Wall Street analysts Materialise NV’s price is currently Overvalued.
Does Materialise NV pay dividends?
Materialise NV does not currently pay dividends.
What is Materialise NV’s EPS estimate?
Materialise NV’s EPS estimate is 0.02.
How many shares outstanding does Materialise NV have?
Materialise NV has 59,067,184 shares outstanding.
What happened to Materialise NV’s price movement after its last earnings report?
Materialise NV reported an EPS of $0.07 in its last earnings report, beating expectations of $0.047. Following the earnings report the stock price went up 11.244%.
Which hedge fund is a major shareholder of Materialise NV?
Currently, no hedge funds are holding shares in MTLS
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Materialise Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Blogger Sentiment
Bullish
MTLS Sentiment 100%
Sector Average ―
Sector Average ―
Hedge Fund Trend
Decreased
By 24.5K Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Very Negative
Last 7 Days ▼ 6.1%
Last 30 Days ▼ 6.0%
Last 30 Days ▼ 6.0%
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Positive
20 days / 200 days
Momentum
38.16%
12-Months-Change
Fundamentals
Return on Equity
―
Trailing 12-Months
Asset Growth
0.60%
Trailing 12-Months
Learn more about TipRanks Smart Score
Company Description
Materialise NV
Materialise N.V. (MTLS), founded in 1990 and headquartered in Leuven, Belgium, is a global leader in additive manufacturing and medical technology. The company offers specialized software and comprehensive 3D printing services across the Americas, Europe, Africa, and Asia-Pacific regions. Its operations are divided into three core segments: 1. Materialise Software: This division develops sophisticated software solutions designed to empower and optimize the functionality of 3D printers and overall 3D printing workflows. Their software acts as a vital bridge, connecting various types of 3D printers with different software applications and data capture technologies, such as computer-aided design/manufacturing suites and 3D scanners. This segment serves a diverse clientele, including manufacturers of 3D printing equipment, production companies, and contract manufacturers in industries like automotive, aerospace, consumer goods, and hearing aids, as well as 3D printing service bureaus. Sales are conducted through their dedicated sales force, online platform, and a network of third-party distributors. 2. Materialise Medical: Focused on healthcare, this segment provides medical software that facilitates advanced medical-image-based analysis and engineering. This capability supports the personalized design of surgical devices and implants tailored to individual patients. Its customer base includes medical device companies, hospitals, universities, research institutions, and industrial firms, with sales handled by a direct sales team, their website, and through partnerships with picture archiving and communication system (PACS) providers. 3. Materialise Manufacturing: This segment delivers end-to-end 3D printing services. It encompasses design and engineering support, rapid prototyping, and the additive manufacturing of final production parts for a broad spectrum of industrial and commercial clients. Materialise N.V. also maintains significant collaboration agreements with several prominent companies in the medical field, including Zimmer Biomet Holdings, Inc.; Encore Medical, L.P.; DePuy Synthes Companies of Johnson & Johnson; Limacorporate Spa; Mathys AG; Corin Ltd; Medtronic Inc.; and Abbott Laboratories Inc.
MTLS Company Deck
MTLS Earnings Call
Q2 2026
0:00 / 0:00
Earnings Call Sentiment|Positive
The call presents a predominantly positive picture: healthy consolidated revenue growth (+8% Q2), clear margin and profitability improvements (adjusted EBITDA +16%, adjusted EBIT expansion), strong cash generation and net cash position, and strategic product and portfolio actions (CO-AM launches, Replasia investment, divestments) that position the company for scalable growth. Offsetting risks include a modest decline in Software revenue and near-term seasonality/costs (asset impairment, working capital increase), and ongoing weakness in certain Manufacturing subsegments (prototyping demand). On balance, the operational and financial momentum and the upgrade to adjusted EBIT guidance outweigh the contained headwinds reported.View all MTLS earnings summariesTechnical Analysis
Ownership Overview
―
Insiders
0.11% Mutual Funds
9.18% Other Institutional Investors
89.96% Public Companies and
Individual Investors